From: Carbonic anhydrase IX in tumor tissue and sera of patients with primary cervical cancer
Carbonic anhydrase IX expression | p-value | |||
---|---|---|---|---|
none/weak | moderate/strong | |||
All samples (n = 221) | 84 | 137 | ||
Histological subtype (n = 221) | squamous | 53 | 108 | 0.024 |
adenomatous | 20 | 15 | ||
adenosquamous | 11 | 14 | ||
FIGO stage (n = 221) | I | 62 | 74 | 0.013 |
II | 15 | 46 | ||
III/IV | 7 | 17 | ||
UICC tumor stage (n = 221) | pT1 | 65 | 76 | 0.001 |
pT2 | 15 | 55 | ||
pT3/4 | 4 | 6 | ||
Nodal involvement (n = 221) | pN0 | 69 | 99 | 0.106 |
pN1 | 15 | 38 | ||
Number of positive lymphnodes (n = 221) | 0 | 69 | 99 | 0.047 |
1-3 | 13 | 23 | ||
>3 | 2 | 15 | ||
Tumor grade (n = 215) | G1 | 9 | 0 | <0.001 |
G2 | 32 | 63 | ||
G3 | 39 | 72 | ||
Lymphovascular space invasion (n = 196) | L0 | 25 | 39 | 0.875 |
L1 | 49 | 83 | ||
Invasion depth in mm (n = 185)* | median | 12 (n = 70) | 16 (n = 115) | 0.025 |
Patients age in years (n = 221)* | median | 49.5 | 47.0 | 0.549 |
SCC-Ag in μg/L (n = 144)* | median | 1 (n = 55) | 1.9 (n = 89) | 0.042 |
Serum CAIX in pg/mL (n = 46)* | median | 91 (n = 17) | 110 (n = 29) | 0.466 |